openPR Logo
Press release

Hemophilia Market to Reach USD 19.09 Billion by 2030, Growing at a CAGR of 5.5% from 2024 to 2030

01-08-2025 11:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Hemophilia Market

Hemophilia Market

๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง

The global Hemophilia market was valued at approximately USD XX.XX billion in 2023 and is projected to grow at a Compound Annual Growth Rate (CAGR) of X.XX% from 2024 to 2030. This market growth is driven by increased awareness of hemophilia, rising government investments in healthcare, and continuous advancements in treatment options.

The market is expected to reach USD XX.XX billion by 2030, with North America and Europe dominating the demand for hemophilia treatments. However, there is also substantial growth potential in Asia-Pacific countries, such as Vietnam, Thailand, Japan, and South Korea.

๐†๐ฅ๐จ๐›๐š๐ฅ ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐š๐ง๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ

The global market for hemophilia is evolving rapidly due to multiple factors including:

๐€๐๐ฏ๐š๐ง๐œ๐ž๐ฌ ๐ข๐ง ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฉ๐ญ๐ข๐จ๐ง๐ฌ : New treatment options, particularly gene therapies and extended half-life factor products, are significantly improving patient outcomes.

๐ˆ๐ง๐œ๐ซ๐ž๐š๐ฌ๐ข๐ง๐  ๐๐ซ๐ž๐ฏ๐š๐ฅ๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š : Rising awareness, early diagnosis, and improved healthcare infrastructure are contributing to the increasing number of diagnosed hemophilia cases.

๐†๐จ๐ฏ๐ž๐ซ๐ง๐ฆ๐ž๐ง๐ญ ๐ˆ๐ง๐ข๐ญ๐ข๐š๐ญ๐ข๐ฏ๐ž๐ฌ : Increased investments by governments and non-profit organizations to provide better access to healthcare for people with rare diseases like hemophilia.

๐‹๐จ๐จ๐ค๐ข๐ง๐  ๐Ÿ๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง? ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐ซ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ง๐จ๐ฐ : https://www.maximizemarketresearch.com/request-sample/67045/

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ: ๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐’๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐”๐’

The United States is anticipated to hold the largest share of the ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ก๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐ฆ๐š๐ซ๐ค๐ž๐ญ due to the advanced healthcare infrastructure and high adoption of new treatment options. The approval of gene therapies such as Hemgenix by ๐๐ข๐จ๐Œ๐š๐ซ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐š๐ง๐ ๐’๐ฉ๐š๐ซ๐ค ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ is expected to further drive the market in the US. The CAGR in the US market is expected to be one of the highest globally, with a substantial rise in demand for advanced treatments and personalized care solutions.

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ : Recent acquisitions like ๐’๐š๐ง๐จ๐Ÿ๐ข'๐ฌ ๐š๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ข๐จ๐ฏ๐ž๐ซ๐š๐ญ๐ข๐ฏ to strengthen its position in the hemophilia treatment market is expected to boost product offerings and distribution networks.

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Europe's hemophilia market is expanding steadily, with increasing investments in healthcare technology. ๐†๐ž๐ซ๐ฆ๐š๐ง๐ฒ, ๐…๐ซ๐š๐ง๐œ๐ž, ๐š๐ง๐ ๐ญ๐ก๐ž ๐”๐Š represent key markets in Europe due to their developed healthcare systems and widespread access to treatment options. Regulatory approvals and national health programs supporting hemophilia treatments play a significant role in this region's growth.

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ : Recent developments like the acquisition of ๐’๐จ๐›๐ข'๐ฌ hemophilia portfolio by ๐’๐ฐ๐ž๐๐ข๐ฌ๐ก ๐Ž๐ซ๐ฉ๐ก๐š๐ง ๐๐ข๐จ๐ฏ๐ข๐ญ๐ซ๐ฎ๐ฆ have added advanced therapies to the market, improving patient outcomes.

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

The ๐‰๐š๐ฉ๐š๐ง๐ž๐ฌ๐ž market for hemophilia is experiencing strong growth due to the increasing healthcare investment in rare diseases. The government's push to expand access to gene therapies and recombinant clotting factor therapies is expected to boost market growth. ๐‰๐š๐ฉ๐š๐ง'๐ฌ innovative approach in drug approvals and its aging population are key drivers of market expansion.

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ: ๐๐จ๐ฏ๐จ ๐๐จ๐ซ๐๐ข๐ฌ๐ค's continuous R&D efforts, combined with the recent acquisitions in Japan, position them as one of the market leaders in this region.

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š

South Korea presents significant opportunities for the hemophilia market due to its progressive healthcare system and rising patient awareness. Public health programs and healthcare initiatives by major players like Shire Pharmaceuticals and Baxalta (now part of Shire, which is owned by Takeda Pharmaceuticals) are contributing to market growth.

๐‘๐ž๐œ๐ž๐ง๐ญ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ: ๐ˆ๐ง๐ญ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐„๐ฆ๐ข๐œ๐ข๐ณ๐ฎ๐ฆ๐š๐› in South Korea and favorable insurance policies for hemophilia treatment are enhancing market prospects.

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ

Vietnam's healthcare market for ๐ก๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š is on the rise, driven by government investments and the increasing availability of treatment options. Rising medical tourism and better healthcare access are expected to contribute to market growth.

๐Œ๐ž๐ซ๐ ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐€๐œ๐ช๐ฎ๐ข๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ฌ: ๐†๐ซ๐ข๐Ÿ๐จ๐ฅ๐ฌ entry into Vietnam's market with its plasma-derived therapies has increased the availability of essential treatments.

๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐

๐“๐ก๐š๐ข๐ฅ๐š๐ง๐ has seen a steady increase in hemophilia cases due to better healthcare access and public awareness campaigns. The Thai government's emphasis on improving healthcare infrastructure is expected to drive the market for hemophilia treatments in the coming years.

๐‘๐ž๐œ๐ž๐ง๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ : The Thai FDA's accelerated approval process for new hemophilia treatments is expected to enhance market access and accelerate product launches.

๐Š๐ž๐ฒ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐†๐ฅ๐จ๐›๐š๐ฅ ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐†๐ž๐ง๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ : Companies such as ๐’๐ฉ๐š๐ซ๐ค ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐š๐ง๐ ๐๐ข๐จ๐Œ๐š๐ซ๐ข๐ง ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ are at the forefront of developing and commercializing gene therapies for hemophilia, offering long-term treatment solutions.

๐„๐ฑ๐ญ๐ž๐ง๐๐ž๐ ๐‡๐š๐ฅ๐Ÿ-๐‹๐ข๐Ÿ๐ž ๐“๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ : The introduction of ๐ž๐ฑ๐ญ๐ž๐ง๐๐ž๐ ๐ก๐š๐ฅ๐Ÿ-๐ฅ๐ข๐Ÿ๐ž ๐Ÿ๐š๐œ๐ญ๐จ๐ซ ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ ๐›๐ฒ ๐œ๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ ๐ฅ๐ข๐ค๐ž ๐๐š๐ฑ๐ญ๐ž๐ซ ๐ˆ๐ง๐ญ๐ž๐ซ๐ง๐š๐ญ๐ข๐จ๐ง๐š๐ฅ ๐š๐ง๐ ๐†๐ซ๐ข๐Ÿ๐จ๐ฅ๐ฌ is revolutionizing the treatment landscape by reducing the frequency of treatments.

๐†๐ฅ๐จ๐›๐š๐ฅ ๐‚๐จ๐ฅ๐ฅ๐š๐›๐จ๐ซ๐š๐ญ๐ข๐จ๐ง๐ฌ : Several global partnerships, such as ๐๐จ๐ฏ๐จ ๐๐จ๐ซ๐๐ข๐ฌ๐ค ๐ฐ๐ข๐ญ๐ก ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š centers and hospitals, are enhancing access to care in underserved regions, particularly in emerging markets.

๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ฌ ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐จ๐ซ ๐ข๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐ญ๐จ๐๐š๐ฒ : https://www.maximizemarketresearch.com/request-sample/67045/

๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ ๐ค๐ž๐ฒ ๐ฌ๐ž๐ ๐ฆ๐ž๐ง๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ ๐ซ๐จ๐ฐ๐ญ๐ก ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ :

๐›๐ฒ ๐“๐ฒ๐ฉ๐ž

Hemophilia A
Hemophilia B
Hemophilia C
Others

With a prevalence four times higher than that of hemophilia type B, hemophilia type A is the most prevalent kind.
The prevalence of type A varies by nation, ranging from 5.4 to 14.5 cases per 100,000 males, according to WebMD LLC data from 2023. Additionally, severe hemophilia A, which is associated with severe bleeding symptoms, was present in about 50-60% of patients. Furthermore, type A hemophilia is treated with the majority of the medications now on the market. Nonetheless, type B is anticipated to develop at the quickest rate over the projected period because of the availability of robust pipeline items. In a similar vein, type B hemophilia makes up about 20% of all hemophilia cases globally, and 50% of these cases have factor IX levels higher than 1%.

๐›๐ฒ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ

On-demand

Prophylaxis

๐›๐ฒ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ

Replacement therapy

ITI therapy
Gene therapy

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž : @https://www.maximizemarketresearch.com/market-report/global-hemophilia-market/67045/

๐‹๐ž๐š๐ซ๐ง ๐š๐›๐จ๐ฎ๐ญ ๐ญ๐ก๐ž ๐ญ๐จ๐ฉ ๐ฉ๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ข๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ :

1. Bayer AG
2. Bio Marin Pharmaceutical, Inc.
3. CSL Behring
4. Kedrion
5. Novo Nordisk
6. Pfizer, Inc.
7. Roche (Chugai Pharmaceutical Co.)
8. Sanofi (Genzyme Corporation)
9. Takeda Pharmaceutical (Shire Plc)
10. Shire (Baxalta)
11. Spark Therapeutics, Inc.
12. Genzyme Corporation
13. Chugai Pharmaceutical Co. Ltd.
14. Novo Nordisk A/S.
15. Octapharma AG

๐†๐ž๐ญ ๐š๐ง๐ฌ๐ฐ๐ž๐ซ๐ฌ ๐ญ๐จ ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐จ๐ง๐ฌ ๐ฌ๐ก๐š๐ฉ๐ข๐ง๐  ๐ญ๐ก๐ž ๐‡๐ž๐ฆ๐จ๐ฉ๐ก๐ข๐ฅ๐ข๐š ๐Œ๐š๐ซ๐ค๐ž๐ญ :

What is Hemophilia ?
What is the growth rate of the Hemophilia Market?
Which are the factors expected to drive the Hemophilia market growth?
What is the CAGR at which the Hemophilia market will grow during the forecast period?
What are the different segments of the Hemophilia Market?
Which is the fastest growing region in the Hemophilia market?
What growth strategies are the players considering to increase their presence in Hemophilia ?
What are the upcoming opportunities and trends for the Hemophilia Market?
What are the recent industry trends that can be implemented to generate additional revenue streams for the Hemophilia Market?
Who are the leading companies and what are their portfolios in Hemophilia Market?
What segments are covered in the Hemophilia Market?
Who are the key players in the Hemophilia market?

๐†๐š๐ข๐ง ๐š๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐จ ๐ฏ๐š๐ฅ๐ฎ๐š๐›๐ฅ๐ž ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/67045/

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ.

Past Size and Competitive Landscape
โ€ข Past Pricing and price curve by region
โ€ข Size, Share, Size Forecast by different segment
โ€ข Dynamics Growth Drivers, Restraints, Opportunities, and Key Trends by Region
โ€ข Segmentation A detailed analysis by segment with their sub-segments and Region
โ€ข Competitive Landscape Profiles of selected key players by region from a strategic perspective

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Global Emotion Detection and Recognition Market https://www.maximizemarketresearch.com/market-report/global-emotion-detection-and-recognition-market/29109/

โ™ฆ Sports Tourism Market https://www.maximizemarketresearch.com/market-report/sports-tourism-market/191030/

โ™ฆ Global Naphthalene Sulfonate Market https://www.maximizemarketresearch.com/market-report/global-naphthalene-sulfonate-market/16198/

โ™ฆ Global Preservative Blends Market https://www.maximizemarketresearch.com/market-report/global-preservative-blends-market/62669/

โ™ฆ Global Transparent Resin Polymer Market https://www.maximizemarketresearch.com/market-report/global-transparent-resin-polymer-market/108267/

โ™ฆ Global Nonwoven Tape Market https://www.maximizemarketresearch.com/market-report/global-non-woven-tape-market/32636/

โ™ฆ Global Inflight Advertising Market https://www.maximizemarketresearch.com/market-report/global-inflight-advertising-market/81621/

โ™ฆ Global Hyperhidrosis Treatment Market https://www.maximizemarketresearch.com/market-report/hyperhidrosis-treatment-market/36627/

โ™ฆ Point-of-Care Ultrasound Market https://www.maximizemarketresearch.com/market-report/point-of-care-ultrasound-market/124678/

โ™ฆ US 3D Printing Medical Devices Market https://www.maximizemarketresearch.com/market-report/us-3d-printing-medical-devices-market/223586/

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

๐‘๐ž๐š๐œ๐ก ๐Ž๐ฎ๐ญ ๐ญ๐จ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐Ÿ๐จ๐ซ ๐ˆ๐ง-๐ƒ๐ž๐ฉ๐ญ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ :

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
sales@maximizemarketresearch.com
www.maximizemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hemophilia Market to Reach USD 19.09 Billion by 2030, Growing at a CAGR of 5.5% from 2024 to 2030 here

News-ID: 3807556 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a Robust 13.71% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Bangladesh Ceramics Tiles Market to Surpass USD 2.1 Billion by 2030, Fueled by a โ€ฆ
Bangladesh Ceramics Tiles Market size was valued at USD 882.56 Million in 2023 and the total Bangladesh Ceramics Tiles Market revenue is expected to grow at a CAGR of 13.71 % from 2024 to 2030, reaching nearly USD 2169.38 Million. Bangladesh Ceramics Tiles Market Overview: The Bangladesh ceramics tiles market is a vital component of the country's construction and building materials industry, driven by rapid urbanization, infrastructure development, and rising disposable incomes.โ€ฆ
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Furfural Market to Reach Nearly USD 1 Trillion by 2030, Propelled by a 6.8% CAGR
Furfural Market size was valued at USD 630.2Mn in 2023. The Furfural Market revenue is growing at a CAGR of 6.8 % from 2023 to 2029, reaching nearly USD 998.30 Bn by 2030. Furfural Market Overview: The furfural market is centered around an organic compound derived primarily from agricultural byproducts such as corn cobs, sugarcane bagasse, and rice husks through a process of acid hydrolysis. As one of the oldest renewable chemicals,โ€ฆ
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to Grow at a 5.59% CAGR Through 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Chemical Protective Clothing Market Valued at USD 1.57 Bn in 2024, Projected to โ€ฆ
Chemical Protective Clothing Market size was valued at USD 1.57 Billion in 2024 and the total Chemical Protective Clothing revenue is expected to grow at a CAGR of 5.59% from 2025 to 2032, reaching nearly USD 2.42 Billion. Chemical Protective Clothing Market Overview: The Chemical Protective Clothing (CPC) market comprises garments and accessories specifically designed to shield workers from exposure to hazardous chemicals, liquids, and particulate matter across a wide range ofโ€ฆ
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR Growth to 2032
09-05-2025 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Prefabricated Homes Market Valued at USD 18.58 Bn in 2024, Poised for 6.19% CAGR โ€ฆ
Prefabricated Homes Market size was valued at USD 18.58 Billion in 2024 and the total Prefabricated Homes revenue is expected to grow at a CAGR of 6.19% from 2025 to 2032, reaching nearly USD 30.04 Billion. Prefabricated Homes Market Overview: The prefabricated homes market, also known as modular or off-site construction, involves the manufacturing of building components in a controlled factory environment before their assembly at the final location. This method revolutionizesโ€ฆ

All 5 Releases


More Releases for Hemophilia

07-29-2025 | Health & Medicine
The Business Research Company
Rising Occurrence Of Genetic Abnormalities Fuels Hemophilia Market Growth: Stren โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Is the Expected CAGR for the Hemophilia Market Through 2025? In recent times, there has been a significant expansion in the hemophilia market. The market, which stood at $13.83 billion in 2024, is projected to inflate to $15.13 billion in 2025, exhibiting a compound annual growth rate (CAGR)โ€ฆ
09-11-2023 | Advertising, Media Consulting, โ€ฆ
Global Market Estimates Research & Consultants
Global Hemophilia Market Size & Trends
According to a new market research report published by Global Market Estimates, the global hemophilia market is projected to grow at a CAGR of 6.8% from 2023 to 2028. During the forecast period, the global hemophilia market is anticipated to experience growth due to advancements in medical research, an increase in hemophilia incidence, and rising awareness and diagnosis. Browse 147 Market Data Tables and 115 Figures spread through 163 Pages andโ€ฆ
06-08-2023 | Business, Economy, Finances, B โ€ฆ
Growth Plus Reports
Acquired Hemophilia Treatment Market - Embracing Hope, Defying Hemophilia: Trans โ€ฆ
Newark, New Castle, USA: The "Acquired Hemophilia Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Acquired Hemophilia Treatment Market: https://www.growthplusreports.com/report/acquired-hemophilia-treatment-market/7748 This latest report researches the industry structure,โ€ฆ
07-29-2018 | Business, Economy, Finances, B โ€ฆ
GlobalMarketForecasts
Hemophilia Market
Hemophilia is an inherited genetic syndrome which impairs body-2019s capability to control blood clotting or coagulation. The episodes of bleeding mainly depend on the severity of hemophilia issue. There are two major kinds of hemophilia namely Hemophilia A & Hemophilia B. Hemophilia A is considered to be five times more prevailing as compared to hemophilia B. Occurrence of hemophilia A is found in one out of five or six thousandโ€ฆ
06-06-2017 | Health & Medicine
ReportsWorldwide
Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Koval โ€ฆ
ReportsWorldwide has announced the addition of a new report title Global Hemophilia Therapeutics Market By Drug (Advate, NovoSeven, Kogenate/Kovaltry, Feiba), By Type of Hemophilia (Hemophilia A, Hemophilia B), By Treatment (On-Demand, Prophylaxis), By Therapy (Replacement , Immune Tolerance Induction ) Outlook 2022 to its growing collection of premium market research reports. Hemophilia is an inherited bleeding disorder that slows the blood clotting process. The people suffering from this condition experience prolongedโ€ฆ
05-15-2017 | Health & Medicine
MarketResearchReports.biz
In-depth analysis of the Global Hemophilia Market: hemophilia A, hemophilia B, h โ€ฆ
Latest industry research report on: Global Hemophilia Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Request For Sample Report @ http://www.marketresearchreports.biz/sample/sample/1064504 The hemophilia market has entered into an era of unprecedented growth rate with a variety of treatment options. Development of new therapeutics along with expansion in the current treatment options has presented new opportunities to the market. Hemophilia being an inherited genetic bleeding disorder causesโ€ฆ